STRATA Skin Sciences, Inc. (SSKN) › Cash & EquivalentsSTRATA Skin Sciences, Inc. (SSKN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2008: $15.07M2009: $29.67M2010: $30.52M2011: $28.00M2012: $7.86M2013: $3.78M2014: $11.43M2015: $3.30M2016: $3.93M2017: $4.07M2018: $16.49M2019: $8.13M2020: $10.60M2021: $12.59M2022: $5.43M2023: $6.78M2024: $7.26M2025: $7.91M$7.91M2008Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$7.91M+9.0%2024$7.26M+7.0%2023$6.78M+24.8%2022$5.43M-56.8%2021$12.59M+18.7%2020$10.60M+30.4%2019$8.13M-50.7%2018$16.49M+305.2%2017$4.07M+3.6%2016$3.93M+18.9%2015$3.30M-71.1%2014$11.43M+202.2%2013$3.78M-51.9%2012$7.86M-71.9%2011$28.00M-8.3%2010$30.52M+2.9%2009$29.67M+96.9%2008$15.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share